Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Oluyemi Okupe	Officer	2026-07-06	29K shares	$1.10M
Carroll Patrick Harrison	Officer	2026-06-18	24K shares	$830K
Becklund Irene	Officer	2026-06-17	4K shares	$141K
Elshenawy Mohamed	Officer	2026-06-17	30K shares	$946K
Chi Michael	Officer	2026-06-17	14K shares	$442K
Becklund Irene	Officer	2026-06-16	8K shares	$229K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-01

2026-07-01

Hims & Hers Health, Inc. entered a $400 million receivables purchase agreement with JPMorgan Chase, under which its subsidiaries can sell eligible receivables for cash. The company also amended its existing credit agreement to accommodate the new facility, adding a $400 million debt basket. The initial term is 364 days, with optional extensions.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding HIMS & HERS HEALTH INC (HIMS)?

Major stakeholders currently include BlackRock, Inc. ($546.8M), Susquehanna International Group, LLP ($520.1M), Jane Street Group, LLC ($277.7M). Based on the latest 13F filings, there are a total of 448 tracked investment funds and institutions maintaining positions in HIMS.

What is the overall institutional sentiment toward HIMS recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.4B, driven by 241 managers accumulating shares while 277 reduced their exposure.

Which institutions have been selling or reducing their HIMS positions?

In the latest period, 146 funds trimmed their holdings, and 131 managers completely exited their positions. The aggregate reported sell value was $5.3B.

Are there any notable investors adding HIMS to their portfolios?

Yes, buying activity remains notable. 78 institutions opened new positions in {ticker}, and 163 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.3B.